GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » 111 Inc (NAS:YI) » Definitions » 3-Year RORE %

111 (YI) 3-Year RORE % : -17.45% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is 111 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. 111's 3-Year RORE % for the quarter that ended in Sep. 2024 was -17.45%.

The industry rank for 111's 3-Year RORE % or its related term are showing as below:

YI's 3-Year RORE % is ranked worse than
64.95% of 97 companies
in the Medical Distribution industry
Industry Median: -0.23 vs YI: -17.45

111 3-Year RORE % Historical Data

The historical data trend for 111's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

111 3-Year RORE % Chart

111 Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
Get a 7-Day Free Trial 18.96 -2.49 20.72 -2.26 -26.65

111 Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.78 -26.65 -27.90 -22.19 -17.45

Competitive Comparison of 111's 3-Year RORE %

For the Medical Distribution subindustry, 111's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


111's 3-Year RORE % Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, 111's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where 111's 3-Year RORE % falls into.



111 3-Year RORE % Calculation

111's 3-Year RORE % for the quarter that ended in Sep. 2024 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.441--0.753 )/( -1.788-0 )
=0.312/-1.788
=-17.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2024 and 3-year before.


111  (NAS:YI) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


111 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of 111's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


111 Business Description

Traded in Other Exchanges
Address
No.295 ZuChongZhi Road, 3rd-5th Floors, Pudong New Area, Shanghai, CHN, 201203
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.